Infection and Immune Aging in Older Adults: A Look at How Immunosenescence Relates to Infections
Official title: Exploratory Study on Infection and Immunosenescence Based on an Elderly Clinical Cohort
Run by Huashan Hospital · NCT07672522 · Data updated 2026-11-12
This study will follow people aged 60 and up to see how aging immune systems relate to infections, comparing healthy seniors with those who have infections.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 484 (estimated) |
| Sponsor | Huashan Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | November 29, 2024 |
| Main results expected | December 30, 2028 |
| Study ends | October 30, 2029 |
| Registry record updated | August 4, 2026 |
| Trial ID | NCT07672522 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults aged 60 or older, including those with recent infections and healthy controls who meet inclusion criteria.
✕Probably not a fit
Some participants may not experience direct personal benefits, as this is an observational study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational cohort will collect clinical data and multiple biological samples from older adults, including blood, urine, stool, sputum, and nasopharyngeal swabs. Researchers will track infection events, health status, and aging-related characteristics over time. The study will analyze immune cell changes, immune receptor patterns, epigenetic marks, metabolic profiles, and microbiota to identify biomarkers linked to immunosenescence and infection susceptibility through integrated clinical and multi-omics data.
Why it matters
Potential benefit: Findings could help identify biomarkers that predict infection risk in older adults and support strategies to improve immune resilience.
How similar studies have gone: Previous research has shown associations between aging immune changes and infection risk, but comprehensive multi-omics integration in this area remains exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for the Healthy Control Group 1. No clinical symptoms suggestive of infection, including fever, cough, dyspnea, fatigue, or myalgia. 2. No abnormal physical signs, including lymphadenopathy, hepatomegaly, splenomegaly, or skin rash. 3. Normal laboratory test results, including complete blood count (CBC), C-reactive protein (CRP), and liver and renal function tests. 4. Healthy adults without underlying chronic diseases, no history of infectious diseases within the previous 6 months, and generally normal cognitive function. 5. Male or female. 6. Able to understand the study procedures and voluntarily provide written informed consent. Inclusion Criteria for the Infection Group 1.Age: 60 years or older; no gender restrictions. 2. Clinically diagnosed with an infectious disease by the treating physician. 3. The participant provides informed consent and signs the relevant documents. \-------------- Exclusion Criteria for the Healthy Control Group 1. Refusal to participate in the study; 2. Any other condition that, in the opinion of the investigator, makes the participant unsuitable for enrollment. Exclusion Criteria for the Infection Group 1. Final primary diagnosis is a non-infectious disease (e.g., connective tissue disease, tumor, or other conditions). 2. Positive culture results are determined by the clinician to be due to colonization or contamination rather than infection. 3. Refusal to participate in the study. 4. Patients in critical or severe conditions who are unable to cooperate with sample collection. 5. Other conditions deemed unsuitable for inclusion as determined by the researchers.
Where it's running
-
Huashan Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Jingwen Ai, MD
- Email: jingwenai1990@126.com
- Phone: 86+13764990804
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Influenza Vaccine Immunogenicity in Older Adults with Repeated Vaccination
This study tests how different flu vaccines perform in adults 65+ who get yearly vaccines to see if age and repeated vaccination affect the immune response.
-
Microbiota Interventions for Accelerated Aging in People with HIV on Alcohol
This study tests whether two safe dietary supplements—Limosilactobacillus reuteri and blueberry extract—can affect immune aging markers in people with HIV who recently used alcohol.
-
Probiotic drink for skin inflammation during the menopausal transition
This study will test whether a daily Lactobacillus casei Shirota probiotic drink can reduce inflammation and improve immune and skin health in women aged 40–60 going through the menopausal transition with inflammatory facial skin conditions.
-
Interferon reference for older people (REFIPA)
This project will test whether measuring type I interferon responses can help identify active respiratory virus infections in people aged 80 and over.
-
VITAL: Try time-restricted eating to improve vaccine responses in older adults
This will test whether four weeks of time-restricted eating (an 8-hour daily eating window) helps people aged 60–85 mount stronger immune responses to seasonal influenza and COVID-19 vaccines.
-
A study on brain health and aging in Bordeaux.
This study is trying to understand how different factors, like diet and health, affect brain aging and the risk of dementia in people aged 55 and older living in Bordeaux.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.